Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: A randomized controlled trial - PubMed
8 hours ago
- #Randomized Controlled Trial
- #Therapeutic Plasma Exchange
- #Acute-on-Chronic Liver Failure
- Therapeutic plasma exchange (TPE) significantly improves 28-day survival in patients with acute-on-chronic liver failure (ACLF).
- TPE compared to standard medical therapy (SMT) reduces 28-day mortality (44.3% vs. 63.9%).
- TPE enhances ammonia reduction and organ failure resolution by day 7 but does not reduce 90-day mortality.
- Common complications from TPE include dyselectrolytemia and shivering.